PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-02-24

Date Title Company
24-Feb-2020 Study Advances Development of Gene Therapy for x-Linked Retinitis Pigmentosa Bascom Palmer Eye Institute
24-Feb-2020 ReNeuron Announces Positive Long-term Data in Retinal Clinical Trial ReNeuron Group plc
24-Feb-2020 ReNeuron Announces Positive Long-term Data in Retinal Clinical Trial ReNeuron Group plc
24-Feb-2020 Avidity Biosciences Announces Presentations at Upcoming Investor Conferences Avidity Biosciences, Inc.
24-Feb-2020 Theravance Biopharma, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update Theravance Biopharma, Inc.
24-Feb-2020 Avanos Medical, Inc. Announces FDA Clearance of its New, 80-Watt COOLIEF* Radiofrequency System for Neurological Lesion Procedures Avanos Medical
24-Feb-2020 Halozyme Announces CFO Transition Halozyme Therapeutics, Inc.
24-Feb-2020 Alkermes' Corporate Presentation to be Webcast at the Cowen and Company 40th Annual Health Care Conference Alkermes plc
24-Feb-2020 Alkermes' Corporate Presentation to be Webcast at the Cowen and Company 40th Annual Health Care Conference Alkermes plc
24-Feb-2020 Shuwen Biotech to Offer Breakthrough Preeclampsia Detection Device Globally through Collaboration with PerkinElmer B3C newswire
24-Feb-2020 Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*) Sanofi
24-Feb-2020 Sartorius Introduces BioPAT® Spectro to Enable Raman Spectroscopy Capability and QbD with its ambr® and BIOSTAT STR® Platforms The Sartorius Group
24-Feb-2020 Almirall and Paratek enter into a License Agreement for Seysara® in China Almirall
24-Feb-2020 Positive long-term data in retinal clinical trial ReNeuron Group plc
24-Feb-2020 ASLAN PHARMACEUTICALS TO PRESENT AT 9th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE ASLAN Pharmaceuticals
24-Feb-2020 FDA approves Lundbeck’s Vyepti™ (eptinezumab-jjmr) – the first and only intravenous preventive treatment for migraine H. Lundbeck A/S
24-Feb-2020 Altair Medical awarded FDA Breakthrough Device designation to address the global opioid crisis Altair Medical
24-Feb-2020 Genmab Board of Directors Chairman to Step Down Genmab
24-Feb-2020 Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2019 Results Presentation and Webcast Nordic Nanovector
24-Feb-2020 Kyowa Kirin Announces Approval of CRYSVITA® (burosumab) in Switzerland for the Treatment of Adults and Children with X-Linked Hypophosphatemia (XLH) Kyowa Kirin Co., Ltd